Join to View Full Profile
US Food and Drug Administration10903 New Hampshire aveSilver Spring, MD 20903
Dr. Naseer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
MedStar Health Georgetown University/Georgetown HospitalFellowship, Infectious Disease, 2006 - 2008
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2003 - 2006
Philadelphia College of Osteopathic MedicineClass of 2003
Certifications & Licensure
MD State License 2010 - 2025
DC State License 2006 - 2010
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 9 citationsCefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy.Xiaohui Wei, Shabnam Naseer, Edward A Weinstein, Dmitri Iarikov, Sumathi Nambiar
Clinical Pharmacology and Therapeutics. 2022-11-01 - 30 citationsUS Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®).Shabnam Naseer, Edward A. Weinstein, Daniel B. Rubin, Kalavati Suvarna, Xiaohui Wei
Clinical Infectious Diseases. 2021-06-15
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
